Results 251 to 260 of about 1,347,718 (326)

An intelligent job scheduling and real-time resource optimization for edge-cloud continuum in next generation networks. [PDF]

Sci Rep
Naeem AB, Senapati B, Rasheed J, Baili J, Osman O.   +4 more
europepmc   +1 more source

British Museum Schedule 3 Release, Yaw Sayana

Stahl, Ann B
openalex   +1 more source

Infrared laser sampling of low volumes combined with shotgun lipidomics reveals lipid markers in palatine tonsil carcinoma

Molecular Oncology, EarlyView.
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff, Manuela Moritz, Dennis Eggert, Anna Worthmann, Joerg Heeren, Henrike Zech, Till S. Clauditz, Waldemar Wilczak, Hartmut Schlüter, Christian S. Betz, Arne Böttcher, Jan Hahn   +11 more
wiley   +1 more source

Multi-access edge computing scheduling optimization model for remote education under 6G network environment based on reinforcement learning. [PDF]

Sci Rep
Jin L, Gao X, Wang J, Yuan S.
europepmc   +1 more source

Testing schedule.

Qiushen Cai (21464246), Huashen Guan (20454677), Junjie Zhang (355622), Xiaoguang Zhang (1397257), Chenfeng Duan (20454680)   +4 more
openalex   +1 more source

On the n-job, one-machine, sequence-independent scheduling problem with tardiness penalties: a branch-bound solution

, 2011
Joel Shwimer
openalex   +2 more sources

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

Molecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala, Sini Ahonen, Sara Peltola, Aura Tuohisto‐Kokko, Olaya Esparta, Peppi Suominen, Anne Jokilammi, Iman Farahani, Deepankar Chakroborty, Nikol Dibus, Steffen Boettcher, Tomi T. Airenne, Mark S. Johnson, Lisa D. Eli, Klaus Elenius, Kari J. Kurppa   +15 more
wiley   +1 more source

Sensor Driven Resource Optimization Framework for Intelligent Fog Enabled IoHT Systems. [PDF]

Sensors (Basel)
Khan S, Shah IA, Loh WK, Khan JA, Mylonas A, Pitropakis N.   +5 more
europepmc   +1 more source

Comfort-Aware Distributionally Robust Chance-Constrained Scheduling of PV-Assisted Heat Pumps under Dynamic Tariffs: A DOE–ANOVA Interaction Analysis

Banu Y. Ekren, Da Huo, Nazmiye Balta-Ozkan   +2 more
openalex   +1 more source

Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity

Molecular Oncology, EarlyView.
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung, David Bickel, Lena C. M. Krause, Daria Ezeriņa, Christian Ickes, Julian Wojtachnia, Christine S. Gibhardt, Magdalena Shumanska, Khadija Wahni, Andrea Paluschkiwitz, Julia Malo Pueyo, Ekaterina Baranova, Wim Vranken, Hedwig Stanisz, Ioana Stejerean‐Todoran, Michael P. Schön, Joris Messens, Ivan Bogeski   +17 more
wiley   +1 more source